finance.yahoo.com
Positivefinance.yahoo.com ·
oncology institute q1 earnings call 050614985
EPU_CATS_HEALTHCAREEPU_CATS_ENTITLEMENT_PROGRAMSWB_1315_TERTIARY_CAREWB_2156_CONTINUUM_OF_CARE
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedOncology Institute's earnings reflect strong growth in value-based care and specialty pharmacy, with expansion in Florida Medicare Advantage. The company is a provider of oncology services; the commercial mechanism is company-specific revenue and margin improvement driven by capitated contracts and patient volume. No direct commodity or supply chain scarcity is indicated.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Q1 revenue up 41% to $147.4 million
- Capitated revenue rose 54% YoY to $26.9 million
- Expanding partnerships into 11 additional Florida counties covering ~200,000 Medicare Advantage lives
- Full-year revenue guidance reaffirmed at $630M-$650M
- Free cash flow outlook raised to positive $5M-$15M